- Home
- DXCM vs KB Comparison
DXCM vs KB Comparison
Compare DXCM & KB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DXCM | KB |
|---|---|---|
| Founded | 1999 | 2008 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 31.3B |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | DXCM | KB |
|---|---|---|
| Price | $67.38 | $86.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 21 | 0 |
| Target Price | ★ $86.86 | N/A |
| AVG Volume (30 Days) | ★ 4.7M | 112.6K |
| Earning Date | 02-12-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 2.32% |
| EPS Growth | 7.75 | ★ 31.42 |
| EPS | 1.80 | ★ 10.70 |
| Revenue | $4,515,900,000.00 | ★ $10,599,662,483.00 |
| Revenue This Year | $17.38 | $17.52 |
| Revenue Next Year | $12.76 | $2.13 |
| P/E Ratio | $37.55 | ★ $7.94 |
| Revenue Growth | ★ 14.21 | 5.94 |
| 52 Week Low | $54.11 | $46.38 |
| 52 Week High | $93.25 | $92.39 |
Technical Indicators
Market Signals| Indicator | DXCM | KB |
|---|---|---|
| Relative Strength Index (RSI) | 58.27 | 52.91 |
| Support Level | $65.56 | $84.61 |
| Resistance Level | $68.18 | $87.61 |
| Average True Range (ATR) | 1.63 | 1.22 |
| MACD | 0.03 | 0.07 |
| Stochastic Oscillator | 44.86 | 70.31 |
Price Performance
Historical ComparisonAbout DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
About KB KB Financial Group Inc
KB Financial Group Inc. is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segments include the Banking business, Securities business, Non-life Insurance business, Credit card business, and Life Insurance business. The Group generates the majority of its revenue from the Banking business.